Laffer Tengler Investments Inc. Increases Stock Position in UnitedHealth Group Incorporated $UNH

Laffer Tengler Investments Inc. raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 46.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 742 shares of the healthcare conglomerate’s stock after acquiring an additional 237 shares during the quarter. Laffer Tengler Investments Inc.’s holdings in UnitedHealth Group were worth $231,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the business. Brighton Jones LLC increased its position in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC boosted its stake in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Fort Sheridan Advisors LLC raised its stake in UnitedHealth Group by 18.5% in the first quarter. Fort Sheridan Advisors LLC now owns 699 shares of the healthcare conglomerate’s stock worth $366,000 after buying an additional 109 shares in the last quarter. Financial Security Advisor Inc. boosted its position in UnitedHealth Group by 9.5% during the 1st quarter. Financial Security Advisor Inc. now owns 2,541 shares of the healthcare conglomerate’s stock valued at $1,331,000 after acquiring an additional 221 shares in the last quarter. Finally, TruNorth Capital Management LLC raised its position in shares of UnitedHealth Group by 137.3% in the 1st quarter. TruNorth Capital Management LLC now owns 318 shares of the healthcare conglomerate’s stock worth $167,000 after acquiring an additional 184 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH opened at $324.29 on Monday. The company has a market capitalization of $293.75 billion, a P/E ratio of 16.93, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The firm has a 50 day moving average of $345.84 and a 200 day moving average of $321.90.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating the consensus estimate of $2.87 by $0.05. The business had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company’s revenue was up 12.2% compared to the same quarter last year. During the same period last year, the business posted $7.15 EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be paid a dividend of $2.21 per share. The ex-dividend date is Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.7%. UnitedHealth Group’s dividend payout ratio is currently 46.14%.

Analysts Set New Price Targets

A number of equities analysts have issued reports on UNH shares. Morgan Stanley increased their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. UBS Group increased their price target on shares of UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a research note on Wednesday, October 29th. TD Cowen boosted their price objective on shares of UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research note on Thursday, October 30th. The Goldman Sachs Group assumed coverage on shares of UnitedHealth Group in a research note on Tuesday, October 14th. They set a “buy” rating and a $406.00 target price for the company. Finally, Zacks Research upgraded UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Eighteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.